MetaVia is trading 11.9% down at $1.48 amid continued technical and sentiment-driven selling following prior financing-related volatility.
- The move occurs on no fresh company-specific news or filings today, suggesting a continuation of recent downward momentum in the thinly traded micro-cap.
- Selling pressure appears driven by broader sector uncertainty in speculative biotech and residual volatility from previous financing activities.